Citations

Clear

48 citation(s) found for "Sauer, JS".

Arrhythmias in Cardiac Sarcoidosis Bench to Bedside
Rosenfeld, Lynda E. , Chung, Mina K. , Harding, Clifford V. , Spagnolo, Paolo , Grünewald, Johan , Appelbaum, Jason, Sauer, William H. , Culver, Daniel A. , Joglar, José A. , Lin, Ben A. , Jellis, Christine , Dickfeld, Timm-Michael, Kwon, Deborah , Cremer, Paul , Bogun, Frank , Bock, Ashley, Mehta, Davendra, Leis, Paul, Siontis, Konstantinos C. , Kaufman, Elizabeth S. , Crawford, Thomas , Zimetbaum, Peter , Zishiri, Edwin , Ellenbogen, Kenneth A. , Quadri, Syed M. , Vincent, Logan , Kalbfleish, Steven, Murgatroyd, Francis , Birnie, David H. , Okada, David R. , Bhat, Pavan , Bellumkonda, Lavanya , Blankstein, Ron , Cheng, Richard K. , Estep, Jerry D. , Cremer, Paul C , Bellumkonda, Lavanya , Cheng, Richard , Ellenbogen, Kenneth A , Dickfeld, Timm-Michael L. , Miller, Edward J. , Kron, Jordana , Singh, Jagmeet P , Chrispin, Jonathan , Patton, Kristen K. , Callahan, Thomas D , Judson, Marc A. , Maulion, Christopher , Blankstein, Ron , Farr, Maryjane

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | February 16, 2021 | Volume: 14 | Issue: 2 | Pages: No page available

10.1161/circep.120.009203 | PMID 33591816 Get It

Cardiac sarcoidosis is a component of an often multiorgan granulomatous disease of still uncertain cause. It is being recognized with increasing frequency, mainly as the result of heightened awareness and new diagnostic tests, specifically cardiac magnetic resonance imaging and 18 F-fluorodeoxyglucose positron emission tomography scans. The purpose of this case-based review is to highlight the potentially life-saving importance of making the early diagnosis of cardiac sarcoidosis using these new tools and to provide a framework for the optimal care of patients with this disease. We will review disease mechanisms as currently understood, associated arrhythmias including conduction abnormalities, and atrial and ventricular tachyarrhythmias, guideline-directed diagnostic criteria, screening of patients with extracardiac sarcoidosis, and the use of pacemakers and defibrillators in this setting. Treatment options, including those related to heart failure, and those which may help clarify disease mechanisms are included.
Local treatment of rhabdomyosarcoma of the female genital tract: Expert consensus from the Children's Oncology Group, the European Soft‐Tissue Sarcoma Group, and the Cooperative Weichteilsarkom Studiengruppe
Lautz, Timothy B. , Martelli, Hélène , Smeulders, Naima , Granberg, Candace F. , Wolden, Suzanne L. , Sparber‐Sauer, Monika , Hawkins, Douglas S. , Bisogno, Gianni , Kościelniak, Ewa , Rodeberg, David A. , group, for the INSTRuCT, Wolden, Suzanne , Bisogno, Gianni , Rodeberg, David A , Seitz, Guido , Hawkins, Douglas S , Lautz, Timothy , Fuchs, Jörg , Chargari, Cyrus , group, for the INSTRuCT

Mayo Clinic

Pediatric Blood & Cancer | August 6, 2020 | Volume: 70 | Issue: 5 | Pages: No page available

10.1002/pbc.28601 | PMID 32762004 Get It

Abstract The International Soft‐Tissue Sarcoma Consortium (INSTRuCT) was founded as an international collaboration between different pediatric soft‐tissue sarcoma cooperative groups (Children's Oncology Group, European Pediatric Soft‐Tissue Sarcoma Group, and Cooperative Weichteilsarkom Studiengruppe). Besides other tasks, a major goal of INSTRuCT is to develop consensus expert opinions for best clinical treatment. This consensus paper for patients with rhabdomyosarcoma of the female genital tract (FGU‐RMS) provides treatment recommendations for local treatment, long‐term follow‐up, and fertility preservation. Therefore, a review of the current literature was combined with recommendations of the treatment protocols of the appropriate clinical trials. Additionally, opinions of international FGU‐RMS experts were incorporated into recommendations. Results were that the prognosis of FGU‐RMS is favorable with an excellent response to chemotherapy. Initial complete surgical resection is not indicated, but diagnosis should be established properly. In patients with tumors localized at the vagina or cervix demonstrating incomplete response after induction chemotherapy, local radiotherapy (brachytherapy) should be carried out. In patients with persistent tumors at the corpus uteri, hysterectomy should be performed. Fertility preservation should be considered in all patients. In conclusion, for the first time, an international consensus for the treatment of FGU‐RMS patients could be achieved, which will help to harmonize the treatment of these patients in different study groups.
Local treatment of rhabdomyosarcoma of the female genital tract: Expert consensus from the Children’s Oncology Group (COG), European Soft Tissue Sarcoma Group (EpSSG), and the Cooperative Weichteilsarkom Studiengruppe (CWS)
Lautz, Timothy B. , Martelli, Hélène , Smeulders, Naima , Granberg, Candace F. , Sauer, Monika Sparber, Hawkins, Douglas S. , Bisogno, Gianni, Kościelniak, Ewa , Rodeberg, David A. , Bisogno, Gianni , Hawkins, Douglas S , Bisogno, Gianni , Lautz, Timothy , Fuchs, Jörg , Chargari, Cyrus , Wolden, Suzanne L. , Sparber‐Sauer, Monika , Seitz, Guido

Mayo Clinic

No container title available | July 1, 2020 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.159363496.66611342 Get It

Background The International Soft Tissue Sarcoma Consortium (INSTRuCT) was founded as an international collaboration between different pediatric soft tissue sarcoma cooperative groups (COG, EpSSG, CWS). Besides other tasks, a major goal of the INSTRuCT is to develop consensus expert opinions for best clinical treatment. This consensus paper for patients with rhabdomyosarcoma of the female genital tract (FGU-RMS) provides treatment recommendations for local treatment, long term follow up and fertility preservation. Methods Review of the current literature was combined with recommendations of the treatment protocols of the appropriate clinical trials. Additionally, opinions of international FGU-RMS experts were incorporated into recommendations. Results The prognosis of FGU-RMS is favorable with an excellent response to chemotherapy. Initial complete surgical resection is not indicated, but diagnosis should be established properly. In patients with tumors localized at the vagina or cervix demonstrating incomplete response after induction chemotherapy, local radiotherapy (brachytherapy) should be carried out. In patients with persistent tumors at the corpus uteri, hysterectomy should be performed. Fertility preservation should be considered in all patients. Conclusion For the first time, an international consensus for the treatment of FGU-RMS patients could be achieved, which will help to harmonize the treatment in different study groups.
Prolonged Inhibition of Presynaptic Catecholamine Synthesis With α-Methyl-Para-Tyrosine Attenuates the Circadian Rhythm of Human TSH Secretion
Zimmermann, Ralf C., Krahn, Lois E., Klee, George G., Ditkoff, Edward C., Sauer, Mark V. , Ory, Steven J.

Mayo Clinic

Journal of the Society for Gynecologic Investigation | July 9, 2017 | Volume: 8 | Issue: 3 | Pages: 174-178

10.1177/107155760100800309 Get It

Natural orifice transluminal endoscopic radical prostatectomy: initial perioperative and pathologic results
Humphreys, M S, Sauer, JS, Ryan, AR, Leslie, KO, Castle, EP, Je, Lingeman, Andrews, PE, Humphreys, M M Smilgin

Mayo Clinic

International braz j urol | February 4, 2012 | Volume: 37 | Issue: 6 | Pages: 786-787

10.1590/s1677-55382011000600018 Get It

Up-regulation of Heat Shock Protein 27 Induces Resistance to 17-Allylamino-Demethoxygeldanamycin through a Glutathione-Mediated Mechanism
McCollum, Andrea K., TenEyck, Cynthia J., Sauer, Brian M. , Toft, David O., Erlichman, Charles

Mayo Clinic

Cancer Research | November 16, 2006 | Volume: 66 | Issue: 22 | Pages: 10967-10975

10.1158/0008-5472.can-06-1629 | PMID 17108135 Get It

Abstract 17-Allylamino-demethoxygeldanamycin (17-AAG), currently in phase I and II clinical trials as an anticancer agent, binds to the ATP pocket of heat shock protein (Hsp90). This binding induces a cellular stress response that up-regulates many proteins including Hsp27, a member of the small heat shock protein family that has cytoprotective roles, including chaperoning of cellular proteins, regulation of apoptotic signaling, and modulation of oxidative stress. Therefore, we hypothesized that Hsp27 expression may affect cancer cell sensitivity to 17-AAG. In colony-forming assays, overexpression of Hsp27 increased cell resistance to 17-AAG whereas down-regulation of Hsp27 by siRNA increased sensitivity. Because Hsp27 is known to modulate levels of glutathione (GSH), we examined cellular levels of GSH and found that it was decreased in cells transfected with Hsp27 siRNA when compared with control siRNA. Treatment with buthionine sulfoximine, an inhibitor of GSH synthesis, also sensitized cells to 17-AAG. Conversely, treatment of Hsp27 siRNA–transfected cells with N-acetylcysteine, an antioxidant and GSH precursor, reversed their sensitivity to 17-AAG. A cell line selected for stable resistance to geldanamycin relative to parent cells showed increased Hsp27 expression. When these geldanamycin- and 17-AAG-resistant cells were transfected with Hsp27 siRNA, 17-AAG resistance was dramatically diminished. Our results suggest that Hsp27 up-regulation has a significant role in 17-AAG resistance, which may be mediated in part through GSH regulation. Clinical modulation of GSH may therefore enhance the efficacy of Hsp90-directed therapy. (Cancer Res 2006; 66(22): 10967-75)